↓ Skip to main content

Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.

Overview of attention for article published in Cancer Genomics & Proteomics, December 2009
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#13 of 146)
  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
Published in
Cancer Genomics & Proteomics, December 2009
Pubmed ID
Authors

Al-Ruwaili JA, Larkin SE, Zeidan BA, Taylor MG, Adra CN, Aukim-Hastie CL, Townsend PA, JAMAL A. AL-RUWAILI, SAMANTHA ET. LARKIN, BASHAR A. ZEIDAN, MATTHEW G. TAYLOR, CHAKER N. ADRA, CLAIRE L. AUKIM-HASTIE, PAUL A. TOWNSEND

Abstract

The incidence of prostate cancer (PCa) has increased in recent years due to the aging of the population and increased testing; however, mortality rates have remained largely unchanged. Studies have shown deficiencies in predicting patient outcome for both of the major PCa diagnostic tools, namely prostate specific antigen (PSA) and transrectal ultrasound-guided biopsy. Therefore, serum biomarkers are needed that accurately predict prognosis of PCa (indolent vs. aggressive) and can thus inform clinical management.

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 5%
Netherlands 1 5%
Unknown 17 89%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 4 21%
Student > Ph. D. Student 3 16%
Researcher 3 16%
Professor 2 11%
Student > Postgraduate 2 11%
Other 5 26%
Readers by discipline Count As %
Medicine and Dentistry 5 26%
Agricultural and Biological Sciences 5 26%
Chemistry 3 16%
Biochemistry, Genetics and Molecular Biology 2 11%
Unspecified 2 11%
Other 2 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2018.
All research outputs
#3,870,885
of 13,104,802 outputs
Outputs from Cancer Genomics & Proteomics
#13
of 146 outputs
Outputs of similar age
#78,775
of 275,468 outputs
Outputs of similar age from Cancer Genomics & Proteomics
#1
of 1 outputs
Altmetric has tracked 13,104,802 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 146 research outputs from this source. They receive a mean Attention Score of 1.3. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,468 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them